Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial
Introduction Infantile spasms (IS) is a type of severe epileptic encephalopathy that occurs in infancy and early childhood. IS is characterised clinically by epileptic spasms, often accompanied by sleep disorder and abnormal circadian rhythm. The endogenous circadian rhythm disorder, in turn, can ma...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-07-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/7/e057970.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832577977448136704 |
|---|---|
| author | Jing Wang Tao Xu Miao Liu Jian Chen Guang Yang Weiwei Feng Yulin Sun Xiuyu Shi Liping Zou |
| author_facet | Jing Wang Tao Xu Miao Liu Jian Chen Guang Yang Weiwei Feng Yulin Sun Xiuyu Shi Liping Zou |
| author_sort | Jing Wang |
| collection | DOAJ |
| description | Introduction Infantile spasms (IS) is a type of severe epileptic encephalopathy that occurs in infancy and early childhood. IS is characterised clinically by epileptic spasms, often accompanied by sleep disorder and abnormal circadian rhythm. The endogenous circadian rhythm disorder, in turn, can make spasms worse. Melatonin has also been found to have anticonvulsant and neuroprotective properties by adjusting the circadian rhythm. However, there are lack of relevant studies on controlling IS by using melatonin. This study aims to analyse the therapeutic effect of melatonin supplementation for the treatment of IS.Methods and analysis This is a triple-blinded (trial participant, outcome assessor and the data analyst), prospective, randomised controlled trial to be conducted in the Department of Paediatrics, The First Medical Center of Chinese PLA General Hospital, Beijing, China from November 2020. Patients (n=70) aged 3 months to 2 years with IS will be recruited in this study after receiving written consent from their parents or guardians. Patients will be randomly divided into two equal groups and treated with a combination of adrenocorticotropic hormone, magnesium sulfate and either melatonin or placebo. Clinical data from the patients in the two groups before and after the treatment will be collected and compared. The primary outcome will be assessed 2 weeks later by seizure diaries and reported as the average reduced rate of spasms frequency. Secondary outcomes include the response rate (the rate of spasms-free), electroencephalogram hypsarrhythmia assessment and the psychomotor development assessment (Denver Developmental Screening Test). Sleep quality and safety will also be assessed.Ethics and dissemination The protocol for this study was approved by the Ethics Committee of Chinese PLA General Hospital (reference number S2020-337-01) and was reported according to the Standard Protocol Items: Recommendations for Interventional Trials statement. Findings of this research will be disseminated through national and international meetings, conferences and peer-reviewed journals.Trial registration number ChiCTR2000036208. |
| format | Article |
| id | doaj-art-a3643f87df7e4b61b13a6295805bb405 |
| institution | Kabale University |
| issn | 2044-6055 |
| language | English |
| publishDate | 2022-07-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-a3643f87df7e4b61b13a6295805bb4052025-01-30T14:25:09ZengBMJ Publishing GroupBMJ Open2044-60552022-07-0112710.1136/bmjopen-2021-057970Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trialJing Wang0Tao Xu1Miao Liu2Jian Chen3Guang Yang4Weiwei Feng5Yulin Sun6Xiuyu Shi7Liping Zou81BeiGene, Beijing, China1 Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, ChinaDepartment of Urinary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaChina International Neuroscience Institute (China-INI), Beijing, ChinaDepartment of Clinical Laboratory, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, ChinaNational Center for Women and Children’s Health, Chinese Center for Disease Control and Prevention, Beijing, ChinaDepartment of Pediatrics, Medical School of Chinese PLA, Beijing, ChinaDepartment of Pediatrics, The First Medical Center of PLA General Hospital, Beijing, ChinaDepartment of Pediatrics, The First Medical Center of PLA General Hospital, Beijing, ChinaIntroduction Infantile spasms (IS) is a type of severe epileptic encephalopathy that occurs in infancy and early childhood. IS is characterised clinically by epileptic spasms, often accompanied by sleep disorder and abnormal circadian rhythm. The endogenous circadian rhythm disorder, in turn, can make spasms worse. Melatonin has also been found to have anticonvulsant and neuroprotective properties by adjusting the circadian rhythm. However, there are lack of relevant studies on controlling IS by using melatonin. This study aims to analyse the therapeutic effect of melatonin supplementation for the treatment of IS.Methods and analysis This is a triple-blinded (trial participant, outcome assessor and the data analyst), prospective, randomised controlled trial to be conducted in the Department of Paediatrics, The First Medical Center of Chinese PLA General Hospital, Beijing, China from November 2020. Patients (n=70) aged 3 months to 2 years with IS will be recruited in this study after receiving written consent from their parents or guardians. Patients will be randomly divided into two equal groups and treated with a combination of adrenocorticotropic hormone, magnesium sulfate and either melatonin or placebo. Clinical data from the patients in the two groups before and after the treatment will be collected and compared. The primary outcome will be assessed 2 weeks later by seizure diaries and reported as the average reduced rate of spasms frequency. Secondary outcomes include the response rate (the rate of spasms-free), electroencephalogram hypsarrhythmia assessment and the psychomotor development assessment (Denver Developmental Screening Test). Sleep quality and safety will also be assessed.Ethics and dissemination The protocol for this study was approved by the Ethics Committee of Chinese PLA General Hospital (reference number S2020-337-01) and was reported according to the Standard Protocol Items: Recommendations for Interventional Trials statement. Findings of this research will be disseminated through national and international meetings, conferences and peer-reviewed journals.Trial registration number ChiCTR2000036208.https://bmjopen.bmj.com/content/12/7/e057970.full |
| spellingShingle | Jing Wang Tao Xu Miao Liu Jian Chen Guang Yang Weiwei Feng Yulin Sun Xiuyu Shi Liping Zou Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial BMJ Open |
| title | Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial |
| title_full | Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial |
| title_fullStr | Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial |
| title_full_unstemmed | Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial |
| title_short | Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial |
| title_sort | melatonin supplementation for the treatment of infantile spasms protocol for a randomised placebo controlled triple blind trial |
| url | https://bmjopen.bmj.com/content/12/7/e057970.full |
| work_keys_str_mv | AT jingwang melatoninsupplementationforthetreatmentofinfantilespasmsprotocolforarandomisedplacebocontrolledtripleblindtrial AT taoxu melatoninsupplementationforthetreatmentofinfantilespasmsprotocolforarandomisedplacebocontrolledtripleblindtrial AT miaoliu melatoninsupplementationforthetreatmentofinfantilespasmsprotocolforarandomisedplacebocontrolledtripleblindtrial AT jianchen melatoninsupplementationforthetreatmentofinfantilespasmsprotocolforarandomisedplacebocontrolledtripleblindtrial AT guangyang melatoninsupplementationforthetreatmentofinfantilespasmsprotocolforarandomisedplacebocontrolledtripleblindtrial AT weiweifeng melatoninsupplementationforthetreatmentofinfantilespasmsprotocolforarandomisedplacebocontrolledtripleblindtrial AT yulinsun melatoninsupplementationforthetreatmentofinfantilespasmsprotocolforarandomisedplacebocontrolledtripleblindtrial AT xiuyushi melatoninsupplementationforthetreatmentofinfantilespasmsprotocolforarandomisedplacebocontrolledtripleblindtrial AT lipingzou melatoninsupplementationforthetreatmentofinfantilespasmsprotocolforarandomisedplacebocontrolledtripleblindtrial |